AI-Powered Cancer Detection and Treatment Partnership Launched in NHS

Strategic Insights -

A pioneering partnership between The Royal Marsden NHS Foundation Trust, NTT DATA, and CARPL.ai marks a significant milestone in the application of artificial intelligence (AI) for cancer research and clinical innovation in the UK's National Health Service (NHS). This collaboration aims to accelerate cancer detection and treatment by leveraging AI-powered radiology analysis services. Funded by a three-year grant from the UK's National Institute for Health and Care Research (NIHR), the service will enable research teams to evaluate AI models across several cancer types, ultimately improving patient outcomes.

Key Takeaways:

  • The partnership involves The Royal Marsden NHS Foundation Trust, NTT DATA, and CARPL.ai, with funding from the UK's National Institute for Health and Care Research (NIHR).
  • The AI-powered radiology analysis service is designed to transform cancer research and improve patient outcomes by accelerating cancer detection and treatment.
  • The service will be used for research at The Royal Marsden and the Institute of Cancer Research (ICR), including projects in collaboration with other research teams.
  • The research initiative will focus on developing and evaluating AI algorithms to improve the accuracy of cancer evaluation, including sarcoma, lung, breast, brain, and prostate cancers.
  • The service runs on a MLOps clinical imaging platform built and operated by NTT DATA.
  • NTT DATA developed a bespoke AI computing solution leveraging high-performance Dell servers and utilizing the latest GPU processing capacity orchestrated by the CARPL.ai platform.
  • NTT DATA is also providing specialist imaging AI consulting services, helping researchers at The Royal Marsden test and evaluate emerging AI tools in real clinical settings.
  • The project represents a collaboration between the NHS, industry, and academia to modernize the NHS and replace outdated systems with cutting-edge digital solutions.

Statistics:

  • The partnership is funded by a three-year grant from the UK's National Institute for Health and Care Research (NIHR).
  • The project aims to improve patient outcomes by accelerating cancer detection and treatment.
  • The AI-powered radiology analysis service will be used for research at The Royal Marsden and the Institute of Cancer Research (ICR).
  • The service will enable research teams to evaluate AI models across several cancer types, including sarcoma, lung, breast, brain, and prostate cancers.
  • NTT DATA developed a bespoke AI computing solution leveraging high-performance Dell servers and utilizing the latest GPU processing capacity.

Sources:

  • Businesswire (Source)
  • The Royal Marsden NHS Foundation Trust (Source)
  • NTT DATA (Source)
  • CARPL.ai (Source)